As per the most recent Enforcement Report by the US Meals and Drug Administration (USFDA), Solar Pharma is recalling Cequa ophthalmic resolution, which is used to deal with persistent dry eye.
The US-based subsidiary of the Mumbai-based drug main is recalling 37,400 cartons (60 vials per carton) of the ophthalmic resolution for being “subpotent”, the US well being regulator stated.
The Princeton (NJ) primarily based agency initiated the nationwide recall of the affected lot on February 22, this yr, it added.
Equally, Dr Reddy’s Laboratories is recalling 10,440 (90-count) and a pair of,24,710 (500 rely) bottles of Atorvastatin Calcium tablets within the US market.
The Hyderabad-based agency is recalling the drug, which is used to forestall heart problems, for “failed impurities/degradation specs”, the USFDA stated.
The US-based unit of the drug main initiated the nationwide recall on February 19, 2021, and the USFDA has categorised it as Class III recall which is initiated in a “state of affairs during which use of, or publicity to, a violative product isn’t more likely to trigger antagonistic well being penalties”.
The drug agency can be recalling 16,449 bottles of Progesterone Capsules (200 mg), used to trigger menstrual intervals in ladies who haven’t but reached menopause, within the US marketplace for “failed dissolution specs”.
The corporate has initiated the nationwide recall of the lot on February 26, this yr and the USFDA has labeled it as a Class II recall which is initiated in a state of affairs during which use of, or publicity to, a violative product might trigger non permanent or medically reversible antagonistic well being penalties or the place the likelihood of significant antagonistic well being penalties is distant.
One other Hyderabad-based drug main Aurobindo Pharma is recalling 1,296 bottles of Famotidine tablets, used to deal with gastroesophageal reflux illness, within the US marketplace for presence of international tablets.
“Famotidine 20mg and ibuprofen 400mg tablets have been present in a whole lot of famotidine 40mg,” the USFDA famous.
The corporate initiated the nationwide recall on January 20 and the USFDA has labeled the motion as Class II.
In addition to, Salisbury-based Jubilant Cadista Prescribed drugs is recalling 6,35,400 cartons of Methylprednisolone tablets, prescribed for its anti-inflammatory and immunosuppressive results, within the American market resulting from “Illegible label”.
“Buyer criticism obtained of misalignment print of the printed dosing directions on the blister card,” the USFDA stated.
The corporate initiated the nationwide recall on February 19 and the USFDA has labeled the motion as a Class III recall.
Jubilant Cadista Prescribed drugs is a subsidiary of Singapore-based Jubilant Pharma, which in flip is a wholly-owned subsidiary of Noida-based Jubilant Life Sciences.